Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Liabilities and Shareholders Equity (2016 - 2025)

Pulmatrix's Liabilities and Shareholders Equity history spans 12 years, with the latest figure at $4.1 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 58.37% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $23.3 million, down 65.51%, while the annual FY2025 figure was $4.1 million, 58.37% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $4.1 million at Pulmatrix, down from $5.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $69.8 million in Q1 2021 and bottomed at $4.1 million in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $35.0 million (2023), against an average of $33.5 million.
  • The largest annual shift saw Liabilities and Shareholders Equity surged 126.62% in 2021 before it tumbled 73.51% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $58.8 million in 2021, then plummeted by 30.37% to $41.0 million in 2022, then decreased by 17.08% to $34.0 million in 2023, then tumbled by 70.72% to $9.9 million in 2024, then tumbled by 58.37% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for PULM's Liabilities and Shareholders Equity are $4.1 million (Q4 2025), $5.0 million (Q3 2025), and $6.2 million (Q2 2025).